RESUMO
<p><b>OBJECTIVE</b>To explore anti-inflammation and mechanism of Qinghuachang Decoction (QD) by using LPS stimulated differentiated colon cancer Caco-2 cells (as an inflammation model of human enterocytes).</p><p><b>METHODS</b>QD was prepared. Human colonic epithelial Caco-2 cells were cultured. Expressions of TNF-alpha and IL-8 were determined using ELISA. Expressions of inhibitory Kaba protein (IkappaB-alpha), phosphorylated inhibitory Kaba protein (p-lkappaB-alpha), nuclear transcription factor p50 (p50), and nuclear transcription factor ReIA (ReIA) protein were determined by Western blot.</p><p><b>RESULTS</b>Compared with the negative control group (without LPS stimulation), LPS stimulated the release of IL-8 and TNF-alpha in Caco-2 cells (P < 0.05). QD treatment could reduce the secretion of TNF-alpha and IL-8 induced by LPS in a dose dependent manner (P < 0.05). QD at 0, 5, 10, and 50 microg/mL had no significant effect on Caco-2 cell survival rates (P > 0.05), with no statistical difference among various concentrations (P > 0.05). QD could significantly suppress nuclear factor-kappa B (NF-kappaB) phosphorylation stimulated by LPS. The expression of p-IKappaB-alpha was decreased with increasing concentrations of QD (P < 0.05). There was no obvious change in IKB-alphaB expressions (P > 0.05). Expressions of p50 and ReIA decreased with increasing concentrations of QD (P < 0.05). Both of them were in a dose dependent manner.</p><p><b>CONCLUSION</b>QD inhibited LPS mediated NF-kappaB activation, which might be one of its mechanisms for treating inflammatory bowel disease (IBD).</p>
Assuntos
Humanos , Células CACO-2 , Colo , Medicamentos de Ervas Chinesas , Farmacologia , Enterócitos , Proteínas I-kappa B , Metabolismo , Inflamação , Interleucina-8 , Lipopolissacarídeos , Inibidor de NF-kappaB alfa , NF-kappa B , Metabolismo , Fosforilação , Fator de Necrose Tumoral alfa , MetabolismoRESUMO
OBJECTIVE@#To explore observing parameters of frontal sinus using reconstructive coronal nose bone sections of the head CT images and to establish the special identification codes.@*METHODS@#CT images of the frontal sinus were analyzed by using distance measurement and morphological description. The discrimination codes of frontal sinus identification were: the number of right partial septa, shape-the location of the central septa, shape-the number of left partial septa, shape; the number of arches of right upper scalloping (the location of the right highest scalloping, the location of the right lowest scalloping)-the number of arches of left upper scalloping (the location of the left highest scalloping, the location of the left lowest scalloping); the width, height of the right sinus-the total width of sinus-the width, height of the left sinus.@*RESULTS@#The identification codes of the frontal sinus were highly variable individually, but the codes were not statistically differences between males and females (P > 0.05).@*CONCLUSION@#The identification codes of frontal sinus could be used for forensic individual identification, but not for sex determination.
Assuntos
Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Adulto Jovem , Povo Asiático , Cefalometria/métodos , China , Análise Discriminante , Antropologia Forense/métodos , Seio Frontal/diagnóstico por imagem , Processamento de Imagem Assistida por Computador/métodos , Tomografia Computadorizada EspiralRESUMO
<p><b>OBJECTIVE</b>To observe the influence of Xianglingwan on dysmenorrhea and serum CA125 in treating patients with endometriosis.</p><p><b>METHOD</b>A total of 54 patients with endometriosis and without medical complications were random selected. Xianglingwan was administered from the fifth day of the menstrual cycle for 3 weeks every month as a therapeutic course, and three months for a therapeutic period. Pelvic type B ultrasonograph and blood CA125 were detected before and after treatment. Visual analogue scale was admitted to evaluate the dysmenorrhea.</p><p><b>RESULT</b>The serum CA125 reduced obviously after therapy. There was a significant difference between them (P < 0.01). The symptom of dysmenorrhea also reduced obviously after treatment. There was a significant difference between them (P < 0.05).</p><p><b>CONCLUSION</b>Xianglingwan can treat edometriosis effectively, and has less adverse reactions, it can also reduce the symptom of dysmenorrheal and the serum CA125.</p>